ES8406480A1 - Un compuesto - Google Patents

Un compuesto

Info

Publication number
ES8406480A1
ES8406480A1 ES522679A ES522679A ES8406480A1 ES 8406480 A1 ES8406480 A1 ES 8406480A1 ES 522679 A ES522679 A ES 522679A ES 522679 A ES522679 A ES 522679A ES 8406480 A1 ES8406480 A1 ES 8406480A1
Authority
ES
Spain
Prior art keywords
theophylline
substituted
salts
substituted theophylline
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522679A
Other languages
English (en)
Spanish (es)
Other versions
ES522679A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES522679A0 publication Critical patent/ES522679A0/es
Publication of ES8406480A1 publication Critical patent/ES8406480A1/es
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
ES522679A 1982-05-24 1983-05-24 Un compuesto Expired ES8406480A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,981 US4451652A (en) 1982-05-24 1982-05-24 Substituted theophylline salts

Publications (2)

Publication Number Publication Date
ES522679A0 ES522679A0 (es) 1984-08-01
ES8406480A1 true ES8406480A1 (es) 1984-08-01

Family

ID=23503202

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522679A Expired ES8406480A1 (es) 1982-05-24 1983-05-24 Un compuesto

Country Status (9)

Country Link
US (1) US4451652A (enExample)
JP (1) JPS58213791A (enExample)
BE (1) BE896802A (enExample)
CA (1) CA1215051A (enExample)
DE (1) DE3318809C2 (enExample)
ES (1) ES8406480A1 (enExample)
FR (1) FR2527211A1 (enExample)
GB (1) GB2121803B (enExample)
IT (1) IT1164234B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543412A (en) * 1983-11-04 1985-09-24 Abbott Laboratories Phenobarbital enzyme inhibitors
CA2341263C (en) * 1999-06-25 2006-08-01 Roche Diagnostics Corporation Enzyme inhibition immunoassay
US6962209B2 (en) * 2001-10-17 2005-11-08 Turfco Manufacturing Inc. Simple, durable and easy-to-use earthworking machine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273866A (en) * 1979-02-05 1981-06-16 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Also Published As

Publication number Publication date
DE3318809A1 (de) 1983-11-24
FR2527211B1 (enExample) 1985-05-17
GB2121803A (en) 1984-01-04
IT1164234B (it) 1987-04-08
JPH0134228B2 (enExample) 1989-07-18
GB2121803B (en) 1985-10-23
US4451652A (en) 1984-05-29
IT8321257A0 (it) 1983-05-24
GB8311847D0 (en) 1983-06-02
BE896802A (fr) 1983-11-21
IT8321257A1 (it) 1984-11-24
DE3318809C2 (de) 1985-01-03
ES522679A0 (es) 1984-08-01
JPS58213791A (ja) 1983-12-12
FR2527211A1 (fr) 1983-11-25
CA1215051A (en) 1986-12-09

Similar Documents

Publication Publication Date Title
FR2334954A1 (fr) Reactif convenant pour la determination immunologique enzymatique
ES8600771A1 (es) Una sonda de acido nucleico marcado.
DE3173712D1 (en) Analysis element for immunochemical measurement of trace components and for enzyme assay and methods using the same
AU4925579A (en) Immunoassay for class specific antibodies
MY100371A (en) Immunoassay for antigents employing supported binder
FI872405A0 (fi) Sjaelvstaendig kylanordning foer livsmedelsbehaollare.
IT7949905A0 (it) Substrato analitico fluorogeno per enzimi proteolitici
FR2602592B1 (fr) Utilisation du systeme enzymatique xanthine-oxydase en immuno-analyse, procedes de dosage correspondants et coffrets de reactifs necessaires pour la mise en oeuvre de ces procedes.
ES541778A0 (es) Una composicion para determinar la presencia de un analito
AU558425B2 (en) Novel compounds
DE2964916D1 (en) Stable immunochemical assay reagent for the determination of haptens, and assay method using said reagent
ATE33671T1 (de) Phenanthridiniumester als markierungsstoff in einem luminometrischen immunoassay.
AU557424B2 (en) Chromogenic tracers for use in an assay
ES485763A1 (es) Un metodo directo para la determinacion de hierro en suero sanguineo
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
MY106970A (en) Substrate composition for alkaline phosphatase and method for assay using same.
MY102067A (en) Coupling agents and products produced therefrom.
ES2052505T3 (es) Procedimiento y reactivo para la determinacion de un participe reaccionante en una reaccion inmunologica.
DE3484857D1 (de) Reagenz zum nachweiss von antigenen.
ES8406480A1 (es) Un compuesto
FR2518096B1 (fr) Procede et reactifs de determination immunologique par polarisation de fluorescence
IT7967300A0 (it) Reagente in particelle per saggi immunologici
GB2135773B (en) Enzyme inhibitor labelled immunoassay
EP0174026A3 (en) Nonspecific-reaction inhibitor in an immunological assay with monoclonal antibody
EP0226903A3 (en) Immunoassay for antibodies to htlv-iii

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001